Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

McNeil Nicotrol, SmithKline Nicoderm transdermal nicotine patches OK for OTC switch -- FDA cmte..

Executive Summary

NICOTROL AND NICODERM PATCHES UNANIMOUSLY RECOMMENDED FOR OTC USE on April 19 by FDA's Nonprescription Drugs Advisory Committee and members of the agency's Drug Abuse Advisory Committee. The committee voted 9-0 that McNeil Consumer Products' Nicotrol and SmithKline Beecham's Nicoderm nicotine transdermal patches are safe and effective for over-the-counter use as smoking cessation aids.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028034

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel